HCPCS Codes Similar to M1412

HCPCS Codes Similar to “M1412” Code.
Patients with metastatic nsclc with epidermal growth factor receptor (egfr) mutations, alk genomic tumor aberrations, or other targetable genomic abnormalities with approved first-line targeted therapy, such as nsclc with ros1 rearrangement, braf v600e mutation, ntrk 1/2/3 gene fusion, met ex14 skipping mutation, and ret rearrangement

A6025 Gel sheet for dermal or epidermal application, (e.g., silicone, hydrogel, other), each Code added date: 19970101 Code effective date: 20070101 TXT \| PDF \| XML \| JSON	S3870 Comparative genomic hybridization (cgh) microarray testing for developmental delay, autism spectrum disorder and/or intellectual disability Code added date: 20090401 Code effective date: 20140101 TXT \| PDF \| XML \| JSON
S3840 Dna analysis for germline mutations of the ret proto-oncogene for susceptibility to multiple endocrine neoplasia type 2 Code added date: 20030701 Code effective date: 20030701 TXT \| PDF \| XML \| JSON	S3855 Genetic testing for detection of mutations in the presenilin - 1 gene Code added date: 20070101 Code effective date: 20150101 TXT \| PDF \| XML \| JSON
S9055 Procuren or other growth factor preparation to promote wound healing Code added date: 20000101 Code effective date: 20000101 TXT \| PDF \| XML \| JSON	S9558 Home injectable therapy; growth hormone, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem Code added date: 20020101 Code effective date: 20020101 TXT \| PDF \| XML \| JSON
G9840 Ras (kras and nras) gene mutation testing performed before initiation of anti-egfr moab Code added date: 20170101 Code effective date: 20180101 TXT \| PDF \| XML \| JSON	G9841 Ras (kras and nras) gene mutation testing not performed before initiation of anti-egfr moab Code added date: 20170101 Code effective date: 20180101 TXT \| PDF \| XML \| JSON
G9834 Patient has metastatic disease at diagnosis Code added date: 20170101 Code effective date: 20210101 TXT \| PDF \| XML \| JSON	G9838 Patient has metastatic disease at diagnosis Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON
G9842 Patient has metastatic disease at diagnosis Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON	G9843 Ras (kras or nras) gene mutation Code added date: 20170101 Code effective date: 20180101 TXT \| PDF \| XML \| JSON
S3831 Single-mutation analysis (in individual with a known mlh1 and msh2 mutation in the family) for hereditary nonpolyposis colorectal cancer (hnpcc) genetic testing Code added date: 20020101 Code effective date: 20120401 TXT \| PDF \| XML \| JSON	S3866 Genetic analysis for a specific gene mutation for hypertrophic cardiomyopathy (hcm) in an individual with a known hcm mutation in the family Code added date: 20090401 Code effective date: 20090401 TXT \| PDF \| XML \| JSON

A6025 Gel sheet for dermal or epidermal application, (e.g., silicone, hydrogel, other), each Code added date: 19970101 Code effective date: 20070101 TXT \| PDF \| XML \| JSON	S3870 Comparative genomic hybridization (cgh) microarray testing for developmental delay, autism spectrum disorder and/or intellectual disability Code added date: 20090401 Code effective date: 20140101 TXT \| PDF \| XML \| JSON
S3840 Dna analysis for germline mutations of the ret proto-oncogene for susceptibility to multiple endocrine neoplasia type 2 Code added date: 20030701 Code effective date: 20030701 TXT \| PDF \| XML \| JSON	S3855 Genetic testing for detection of mutations in the presenilin - 1 gene Code added date: 20070101 Code effective date: 20150101 TXT \| PDF \| XML \| JSON
S9055 Procuren or other growth factor preparation to promote wound healing Code added date: 20000101 Code effective date: 20000101 TXT \| PDF \| XML \| JSON	S9558 Home injectable therapy; growth hormone, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem Code added date: 20020101 Code effective date: 20020101 TXT \| PDF \| XML \| JSON
G9840 Ras (kras and nras) gene mutation testing performed before initiation of anti-egfr moab Code added date: 20170101 Code effective date: 20180101 TXT \| PDF \| XML \| JSON	G9841 Ras (kras and nras) gene mutation testing not performed before initiation of anti-egfr moab Code added date: 20170101 Code effective date: 20180101 TXT \| PDF \| XML \| JSON
G9834 Patient has metastatic disease at diagnosis Code added date: 20170101 Code effective date: 20210101 TXT \| PDF \| XML \| JSON	G9838 Patient has metastatic disease at diagnosis Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON
G9842 Patient has metastatic disease at diagnosis Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON	G9843 Ras (kras or nras) gene mutation Code added date: 20170101 Code effective date: 20180101 TXT \| PDF \| XML \| JSON
S3831 Single-mutation analysis (in individual with a known mlh1 and msh2 mutation in the family) for hereditary nonpolyposis colorectal cancer (hnpcc) genetic testing Code added date: 20020101 Code effective date: 20120401 TXT \| PDF \| XML \| JSON	S3866 Genetic analysis for a specific gene mutation for hypertrophic cardiomyopathy (hcm) in an individual with a known hcm mutation in the family Code added date: 20090401 Code effective date: 20090401 TXT \| PDF \| XML \| JSON